Device Trial Radar · NCT02685956
Clinical Evaluation of the Sentosa SA HSV1/2 Qualitative PCR Test
Last checked: Nov 20, 2026Latest source record: Jun 5, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
2,295
Actual
Start
Apr 2016
Primary completion
Apr 7, 2017
Study completion Apr 7, 2017
Sponsor
- Lead sponsor
- Vela DiagnosticsNot on our public-company list
- Sponsor type
- Industry
- First posted
- Feb 19, 2016
Design
- Study type
- Observational
- Who can join
- All sexes
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the performance of the Sentosa SA HSV1/2 Qualitative PCR Test. Precision of results and concordance of results with a reference assay will be evaluated.
Conditions
- Herpes Simplex
Interventions
Vela Sentosa SA HSV1/2 Qualitative PCR TestDevice
medical device test using Vela Sentosa SA HSV1/2 Qualitative PCR Test
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants Positive and Negative for HSV-1 by SA201 HSV-1/2 PCR TestTime frame: within 60 days of last sample enrollment
1 more outcomes with a free account
Locations
9 sites in 1 country. Site status is shown where the registry gives one.
Tampa General Hospital
Tampa, Florida
8 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.